On December 14, Abbott China announced adjustments to its nutrition business, planning to gradually quit the operation and sales of infant andethinylestradiol levonorgestrel ferrous fumarate price child nutritionaferrous fumarate 324 mg tabl products in the Chinese mainland market. Instead, it will mainly focus on developing the medical nutrition business. According to Abbott China, Chinese consumers&39; demands for infant and children&39;s nutrition products have been changing. Meanwhile, there is an increasing awareness of scientific nutrition amonnursing interventions for ferrous sulfateg adults, which makes them concentrate on growing medtime release capsules of ferrous fumarate usesical nutrition business in the Chinese mainland markferrous gluconate dose canadaet.
Abbott China Announced to Gradually Quit Infant and Child Nutrition Business in the Chinese Mainland Market
